Shingles vaccination in immune-mediated inflammatory diseases: a narrative review
Ark, Rajiv Allen, Victoria Bechman, Katie Yang, Zijing Nagra, Deepak Russell, Mark D Galloway, James
Ark, Rajiv
Allen, Victoria
Bechman, Katie
Yang, Zijing
Nagra, Deepak
Russell, Mark D
Galloway, James
Affiliation
Other Contributors
Publication date
2026-02-04
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
There are several pressing reasons to re-examine shingles and strategies for its prevention through vaccination. Firstly, the UK has recently recommended the introduction of a national childhood varicella vaccination programme, and this may impact the epidemiology of shingles. Secondly, treatments for immune-mediated inflammatory diseases are increasingly targeting immunological pathways essential for antiviral defence. Thirdly, we now have access to a highly efficacious shingles vaccine. This review article will explore each of these developments in a way that is globally relevant, incorporating international recommendations.
Citation
Ark R, Allen V, Bechman K, Yang Z, Nagra D, Russell MD, Galloway J. Shingles vaccination in immune-mediated inflammatory diseases: a narrative review. Rheumatology (Oxford). 2026 Feb 4;65(2):keag043. doi: 10.1093/rheumatology/keag043.
Type
Article